Skip to main content
Log in

Ciprofloxacin induced hypersensitivity vasculitis syndrome

  • Letters to the Editor
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Wilson, Braunwald, Isselbacher, Martin, Callci, Root.Harrisons's Principles of Internal Medicine. Vol. II, 12th edn, New York: McGraw Hill, 1991: 1456–1463.

    Google Scholar 

  2. Donato Alarcon Segovia. The necrotizing vasculitides, a new pathogenic classification.Med Clin North Am March 1977; 61(2): 241–260.

    Google Scholar 

  3. Banker BQ, Victor M. Dermatomyostis (systemic angiopathy) of childhood.Medicine 1966; 45: 261–289.

    Article  PubMed  CAS  Google Scholar 

  4. Copps TR, Springes RM, Falla AS.Jama 1982; 247(14): 1994–1998.

    Article  Google Scholar 

  5. Frieden TR et al. Inappropriate use of oral ciprofloxacin.JAMA 1990; 264(II): 1438–1440.

    Article  PubMed  CAS  Google Scholar 

  6. Davis H, Mcgoodwin E, Greene Reed T. Anaphylactoid reactions reported after treatment with ciprofloxacin.Ann Intern Med 1989; III: 1041–1043.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagh, S.S., Karmarkar, D.P. & Rajput, C.S. Ciprofloxacin induced hypersensitivity vasculitis syndrome. Indian J Pediatr 60, 610–611 (1993). https://doi.org/10.1007/BF02751448

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02751448

Keywords

Navigation